Samsung Bioepis Secures Marketing Authorization for Autoimmune Disease Treatment in Japan 한광범 2025.12.23 오전 09:58 Liquid biopsy·AI·3D printing lift Korea’s platform tech trio[K-bio Pulse] 김승권 2025.12.26 오전 08:00 The Achilles’ Heel of Korea’s Biopharma Giants[Yoo Sung’s Pharma National Wealth Theory] 류성 2025.05.15 오전 06:24 AimedBio and Two Others Hit Upper Limit, Featured in Stock Market Top 10 Gainers... Just the Begi... 유진희 2025.12.08 오전 08:00 Samsung Epis Holdings rebounds on new drug IND filing [K-Bio Pulse] 임정요 2025.12.04 오전 08:15 Samsung Biologics to split off biosimilar business 임정요 2025.05.22 오후 04:06 Samsung Bioepis unveils new research on autoimmune biosimilars at IMKASID 2025 김진수 2025.04.10 오후 04:34 Samsung Bioepis’ biosimilar EPYSQLI now available in the U.S. 임정요 2025.04.08 오전 11:16 Samsung Biologics Sets Q1 Sales Record...Eyes KRW 5T Year 김승권 2025.04.23 오후 04:50 COVID19 and Avian Flu Resurgence Fears Send Shinpoong·Thebiomed Soaring[K-bio Pulse] 신민준 2025.05.23 오전 09:00 더 보기 로딩중..